CS-6253

N/A

Report date: 2024/12/18 13:39:48

Base Information

Drug NameCS-6253
Drug Alias NameCS-6253
ClassificationBiologics
Mechanisms of ActionATP binding cassette subfamily A member 1 stimulants
TargetsATP binding cassette subfamily A member 1
Therapy Area/IndicationsDiabetes Mellitus, Type 2AtherosclerosisAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of California, Berkeley
China Registration ClassN/A

Develop Information

Active CompaniesArtery Therapeutics IncUniversity Of California, Berkeley
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2AtherosclerosisAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A